Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02014402 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery
A Phase 2 study, sponsored by Instituto Grifols, S.A..
- Completed
- Registry status
- Phase 2
- Development phase
- 181
- Enrollment target
NCT02014402 is a Phase 2 study that has completed, run by Instituto Grifols, S.A.. The registered enrollment target is 181 participants.
The verdict
NCT02014402, a Phase 2 study, has completed, sponsored by Instituto Grifols, S.A..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 181 participants
- Enrollment target
Study Summary
This purpose of this clinical trial was to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, liver, soft tissue, and spinal surgical procedures.
Interventions
- BIOLOGICAL Human thrombin
- BIOLOGICAL Bovine thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02014402
The ClinicalTrials.gov registry entry for NCT02014402 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Instituto Grifols, S.A., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Human thrombin is the first listed.
NCT02014402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02014402 about?
NCT02014402 is a clinical study titled "Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery". This purpose of this clinical trial was to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, liver, soft tissue, and spinal surgical procedures.
What is the current status of trial NCT02014402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 181 participants. The study started on 2013-12. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02014402?
The interventions under investigation include: Human thrombin (BIOLOGICAL), Bovine thrombin (BIOLOGICAL).
Who is sponsoring clinical trial NCT02014402?
This trial is sponsored by Instituto Grifols, S.A., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.